Comparing pain relief methods after day surgeries
Preemptive Intravenous Paracetamol Plus Tramadol Versus Preemptive Intravenous Fentanyl in Day Case Surgeries
This study is testing whether a mix of paracetamol and tramadol works better than intravenous fentanyl for managing pain after day surgeries to see which option helps patients feel better and recover faster.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 132 (estimated) |
| Ages | 21 Years to 60 Years |
| Sex | All |
| Sponsor | Zagazig University Government |
| Locations | 1 site (Zagazig, Sharquia) |
| Trial ID | NCT05990686 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of preemptive analgesia using a combination of paracetamol and tramadol versus intravenous fentanyl in managing postoperative pain for patients undergoing day case surgeries. Patients will be monitored for vital signs and pain levels at various intervals post-surgery. The study aims to determine which analgesic strategy provides better pain control and patient satisfaction, potentially leading to improved recovery outcomes.
Who should consider this trial
Good fit: Ideal candidates are patients aged 21 to 60 scheduled for day case surgeries with ASA physical status I or II and a BMI between 25 and 30.
Not a fit: Patients with chronic pain, liver or renal impairment, or those who are uncooperative may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance postoperative pain management, leading to quicker recovery and higher patient satisfaction.
How similar studies have performed: Other studies have shown varying success with different analgesic combinations, but this specific comparison is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients scheduled for day case surgeries. * Both sex * Patient's age 21 - 60 years. * Patients with ASA physical status I, II. * BMI 25 - 30 kg m-2. Exclusion Criteria: * Uncooperative patients and patients with psychological problems. * Patients with liver or renal impairment.. * Patients with history of allergy to drug used in the study. * Patients with chronic pain.
Where this trial is running
Zagazig, Sharquia
- Zagazig University , Fuculty of Medicine — Zagazig, Sharquia, Egypt (Recruiting)
Study contacts
- Principal investigator: MICHAEL A shaker, lecturer — Zagazig University
- Study coordinator: michael A shaker, lecturer
- Email: michaeladelshaker@yahoo.com
- Phone: 01220647566
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.